Immunotherapy drug doubles cancer-free survival in head and neck cancer patients
BBC - 31-May-2025Pembrolizumab doubled cancer-free survival from 2.5 to 5 years and cut spread risk by 10%
The Institute of Cancer Research (ICR)
One of the world’s most influential cancer research organizations
The ICR is led by Chief Executive Professor Kristian Helin — known for his pioneering scientific discoveries in cancer epigenetics.
We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy.
Together with our hospital partner The Royal Marsden NHS Foundation Trust, we are rated as one of the top centres for cancer research and treatment worldwide.
As well as being as world-class research institute, the ICR is a higher education institution and a member institution of the University of London. We came top in the league table of university research quality compiled from the Research Excellence Framework (REF 2014).
Visit website: https://www.icr.ac.uk/
the-institute-of-cancer-research
Details last updated 04-Feb-2019
The Institute of Cancer Research (ICR) News
AI can predict how early breast cancer patients might respond to their treatments
Durham University - 09-Feb-2024This could lead to more personalised treatment plans and better outcomes
AI model shows promise in speeding up cancer detection and diagnosis
The Guardian - 30-Apr-2023Potential to fast-track patients to treatment and streamline CT scan analysis
New breast cancer drug offers hope for thousands: extends life and reduces tumors
Independent - 08-Dec-2022Capivasertib could become a game-changer for advanced breast cancer patients
Scientists unveil role of genomic 'dark matter' in cancer detection and treatment
BBC - 27-Oct-2022Early but promising finding that epigenetic changes alter the growth of cancer cells
Display all news
People at The Institute of Cancer Research (ICR)
Kevin Harrington
Consultant Clinical Oncologist and Professor specializes in Biological Cancer Therapies, head and neck cancer, immunotherapy
Rajesh Chopra
Head of the Division of Cancer Therapeutics, Institute of Cancer Research and Royal Marsden Hospital.
Nicola Valeri
Team Leader of Gastrointestinal Cancer Biology and Genomics at The Institute Of Cancer Research.
Andrea Sottoriva
Professor of Cancer Genomics & Evolution and Deputy Director of the Centre for Evolution and Cancer.
